Skip to main content
Caplight Logo









Filtravate

Filtravate

Private
Las Cruces, New MexicoHealthcare & Life Scienceshttps://filtravate.com/

Last Round

Grant

Jan 2, 2024

Total Funding Raised

$956,000

Company Overview

Filtravate is a biotechnology company that develops and commercializes advanced ultrafiltration membranes for use in bioprocessing and biopharmaceutical manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

ultrafiltration membranesbioprocessingmonoclonal antibody productionmAbviral clearancemembrane foulingsingle-use biomanufacturingbiotech equipmentfiltration mediacontinuous bioprocessingbioprocess engineeringbiotech consumablesmembrane technologybiopharma manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Filtravate Comparables

Compare Filtravate with similar companies based on industry and business-model similarity.

Filtravate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Danaher Corporation
74%
Meissner
73%
Asahi Kasei
71%

Filtravate Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 2, 2024
GrantSep 19, 2022
AngelFeb 14, 2022
SeedFeb 26, 2020

Filtravate Investors

Notable investors and investment history

Filtravate investors
InvestorRounds
VIC Investor NetworkSeed
Department of EnergyGrant
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 2, 2024

    $400K grant from Department of Energy and NM program.

  • Feb 14, 2022

    $300K raised in an angel round.

Filtravate Filings

Explore SEC and related filing metadata, where available.

Filtravate filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Filtravate's valuation, stock price, and market status.

Is Filtravate a public or private company?

Filtravate is a private company.

What is the current stock price of Filtravate?

Filtravate is a private company with no public stock price. No recent secondary market data is available.

How much is Filtravate worth (valuation)?

Valuation information for Filtravate is not publicly available.

Can I buy Filtravate stock?

Filtravate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Filtravate's last funding round?

Filtravate's most recent funding round was Grant on January 2, 2024.

Who are the main investors in Filtravate?

Key investors in Filtravate include VIC Investor Network, Department of Energy, National Science Foundation.

Will Filtravate IPO soon?

No public IPO plans have been announced for Filtravate.

How can I track Filtravate secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Filtravate's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLas Cruces, New Mexico
Employee Range1
Year Founded2020
Last FundingJan 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?